Discriminative capacity of fasting C-peptide levels in a functional test according to different criteria of response to a stimulus. A study of Brazilian insulin-dependent diabetic patients

Acta Diabetologica

Volumn 34, Issue 1, 1997, Pages 42-45

  Pozzan, R ^a,b   Dimetz, T ^a   Gazolla, H M ^a   Gomes, M B ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

C peptide functional test; Insulin dependent diabetes

Indexed keywords

C PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS FUNCTION TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0030980194     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920050064     Document Type: Article

References (14)

1. Faber OK, Binder C, C-peptide response to glucagon: a test for the residual B-cell function in diabetes mellitus. Diabetes 26: 605-610, 1977
2. Nakanishi K, Kobayashi T, Murase T, Kobasa K, Residual B-cell function and HLA-A24 in IDDM. The markers of early progression of diabetic retinopathy. Proceedings of the 15th International Diabetes Federation Congress, Kobe, Japan, p 193, abst 0154, 1994
3. Sberna P, Valentini V, Cimino A, Sabathi MC, Rotondi A, Criseti G, Spandrio S, Residual B-cell function in insulin-dependent (type I) diabetics with and without retinopathy. Acta Diabetol Lat 23:339-344, 1986
4. Schiffrin A, Suissa S, Witzner G, Poussier P, Lalla D, Factors predicting course of B-cell function in IDDM Diabetes Care 15:997-1001, 1992
5. Rjasanowsky I, Michaelis D, Keilacker H, Besch W, Richter KV, Heinke P, 5-Year follow-up study of C-peptide secretion in newly diagnosed type I diabetics; relations to HLA-phenotype, insulin requirement and metabolic control. Exp Clin Endocrinol 89:216-224, 1987
6. Kobayashi T, Nakanishi K, Sugimoto T, Itoh T, Minase T, Kosaka K, Tsuji K, Maleness as a risk factor for slowly progressive IDDM, Diabetes Care 12:7-11, 1989
7. Clarson C, Daneman D, Drash AL, Becker DJ, Ehrlich RM, Residual B-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care 10:33-38, 1987
8. Garcia-Webb P, Bonser A, Welborn TA, Correlation between fasting serum C-peptide and B-cell insulin secretory capacity in diabetes mellitus. Diabetologia 22:296, 1982
9. The DCCT Research Group, Effect of age, duration and treatment of insulin dependent diabetes mellitus on residual B-cell function: observation during eligibility testing for the Diabetes Control and Complication Trial (DCCT). J Clin Endocrinol Metab 65:30-36, 1987
10. Eff C, Faber O, Deckert T, Persistent insulin secretion, assessed by plasma C-peptide estimation, in long-term juvenile diabetes with a low insulin requirement. Diabetologia 15:169-172, 1978
11. Gjessing HJ, Matzen LE, Faber OK, Froland A, Fasting plasma C-peptide, glucagon stimulated C-peptide and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 32: 305-311, 1989
12. Maislos M, Bodiner-Fishman B, Weitzman S, Prevalence and clinical characteristics of type I and II insulin - treated diabetes in the community. Diabetes Care 17:1230-1231, 1994
13. Hother Nielsen O, Faber O, Sorensen NS, Beck Nielsen H, Classification of newly diagosed diabetic patients as insulin requiring and non-insulin requiring based on clinical and biochemical variables. Diabetes Care 11:531-537, 1988
14. National Diabetes Data Group, Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 28:1039-1058, 1979